{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03233074",
      "OrgStudyIdInfo": {
        "OrgStudyId": "2017-0701"
      },
      "SecondaryIdInfoList": {
        "SecondaryIdInfo": [
          {
            "SecondaryId": "2017-A02088-45",
            "SecondaryIdType": "Other Identifier",
            "SecondaryIdDomain": "ANSM"
          }
        ]
      },
      "Organization": {
        "OrgFullName": "Institut de Cancérologie de la Loire",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors",
      "OfficialTitle": "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)",
      "Acronym": "COSMOS"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2021",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "November 17, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "September 30, 2021",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "September 30, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "July 17, 2017",
      "StudyFirstSubmitQCDate": "July 25, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 28, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 22, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 25, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Institut de Cancérologie de la Loire",
        "LeadSponsorClass": "OTHER"
      },
      "CollaboratorList": {
        "Collaborator": [
          {
            "CollaboratorName": "Centre Hospitalier Universitaire de Saint Etienne",
            "CollaboratorClass": "OTHER"
          }
        ]
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "It is of clinical significance to better characterize the intrinsic defects harbored by mesenchymal stromal cells (MSC) in Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) context, as compared to physiological conditions. Such research initiative aims to dissect the cross-talk between malignant hematopoietic stem cells (HSC) and their bone marrow (BM) partners in crime, further prospecting for innovative stromal-directed strategies for the treatment of Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).",
      "DetailedDescription": "Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal malignancies that are characterized by ineffective hematopoiesis, progressive bone marrow failure, cytogenetic and molecular abnormalities, and increased risk for progression to acute myeloid leukemia (AML). It is a well-accepted theory that MDS and AML originate from primary alterations of hematopoietic stem cells (HSC) compartment, which confer a survival advantage to them at the expense of physiological hematopoiesis. More recently, there is growing evidences regarding the contribution of the bone marrow (BM) microenvironment to the pathogenesis of MDS and AML. Of particular interest, several studies have pointed towards a pivotal role of mesenchymal stromal cells (MSC), one of the main components of the BM niche, in the initiation and propagation of myeloid disorders. In this context, it is of clinical significance to better characterize the intrinsic defects harbored by MSC in MDS and AML context, as compared to physiological conditions. Such research initiative aims to dissect the cross-talk between malignant HSC and their BM partners in crime, further prospecting for innovative stromal-directed strategies for the treatment of MDS and AML."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Myelodysplastic Syndromes",
          "Acute Myeloid Leukemia",
          "Cardio-vascular Surgery"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Myelodysplastic Syndromes",
          "Acute Myeloid Leukemia",
          "Bone Marrow",
          "Mesenchymal stromal cell",
          "Healthy donor"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Case-Control"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "BioSpec": {
        "BioSpecRetention": "Samples With DNA",
        "BioSpecDescription": "Bone marrow"
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "150",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Acute Myeloid Leukemia patients",
            "ArmGroupDescription": "For diagnosis purpose, bone marrow sampling is performed for acute myeloid leukemia patients. 2 milliliters of this sample will be collected and analysed for the COSMOS study.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Bone marrow analyses"
              ]
            }
          },
          {
            "ArmGroupLabel": "Healthy donors",
            "ArmGroupDescription": "Healthy donors are patients undergoing cardio-vascular surgery for their usual support. During this surgery, 2 milliliters of the bone marrow will be collected, and analysed for the COSMOS study.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Bone marrow analyses"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Bone marrow analyses",
            "InterventionDescription": "This is a non-interventional study for the constitution of a biobank of bone marrows, in order to further investigate in vitro the cellular properties of bone marrow-isolated mesenchymal stromal cells.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Acute Myeloid Leukemia patients",
                "Healthy donors"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "Cellular properties of mesenchymal stromal cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Changes in cellular properties of mesenchymal stromal cells",
            "PrimaryOutcomeDescription": "Changes in cellular properties of mesenchymal stromal cells isolated from bone marrow aspirates by comparing normal cells (i.e. healthy donors) and MDS/AML cells.",
            "PrimaryOutcomeTimeFrame": "Day 0"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Number of differential biomarkers in mesenchymal stromal cells",
            "SecondaryOutcomeDescription": "Number of differential biomarkers expressed by MDS or AML-derived mesenchymal stromal cells",
            "SecondaryOutcomeTimeFrame": "Day 0"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with diagnosed myelodysplasia or acute myeloid leukemia (study place: ICLN) - Specific to the cases cohort\nAge-matched healthy donors undergoing a cardiovascular surgery - Specific to the control cohort\nSigned written informed consent form\nPatient affiliated to a social security regimen or beneficiary of the same\n\nExclusion Criteria:\n\nMedical history of hematological disorders\nThrombocytopenia, anemia…\nPatient under guardianship or deprived of his liberty or any condition that may affect the patient's ability to understand and sign the informed consent (art. L.1121-6, L.112-7, L.1211-8, L.1211-9)\nPregnant or breastfeeding women\nRefusing participation",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "50 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "Acute Myeloid Leukemia patients undergoing a bone marrow sampling for diagnosis purposes, and healthy donors undergoing cardio-vascular surgery for their usual support.",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Denis Guyotat, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "(0)4 77 91 70 70",
            "CentralContactPhoneExt": "+33",
            "CentralContactEMail": "denis.guyotat@icloire.fr"
          },
          {
            "CentralContactName": "Elisabeth Daguenet, PhD",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "(0)4 77 91 70 89",
            "CentralContactPhoneExt": "+33",
            "CentralContactEMail": "Elisabeth.daguenet@icloire.fr"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Denis Guyotat, PhD",
            "OverallOfficialAffiliation": "Institut de Cancérologie Lucien Neuwirth",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "CHU de Saint-Etienne",
            "LocationStatus": "Recruiting",
            "LocationCity": "Saint-Priest-en-Jarez",
            "LocationZip": "42270",
            "LocationCountry": "France",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Jean-François Fuzelier, PhD",
                  "LocationContactRole": "Contact"
                },
                {
                  "LocationContactName": "Jean-François Fuzelier, PhD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          },
          {
            "LocationFacility": "Institut de Cancérologie Lucien Neuwirth",
            "LocationStatus": "Recruiting",
            "LocationCity": "Saint-Priest-en-Jarez",
            "LocationZip": "42270",
            "LocationCountry": "France",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Denis Guyotat, PhD",
                  "LocationContactRole": "Contact"
                },
                {
                  "LocationContactName": "Denis Guyotat, PhD",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Jérôme Cornillon, PhD",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Fressia Honeyman, PhD",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Caroline Lejeune, PhD",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Christiane Mounier, PhD",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Christelle Portois, PhD",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Gilbert Soglu, PhD",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Emmanuelle Tavernier, PhD",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007951",
            "ConditionMeshTerm": "Leukemia, Myeloid"
          },
          {
            "ConditionMeshId": "D000015470",
            "ConditionMeshTerm": "Leukemia, Myeloid, Acute"
          },
          {
            "ConditionMeshId": "D000011289",
            "ConditionMeshTerm": "Preleukemia"
          },
          {
            "ConditionMeshId": "D000009190",
            "ConditionMeshTerm": "Myelodysplastic Syndromes"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000007938",
            "ConditionAncestorTerm": "Leukemia"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000001855",
            "ConditionAncestorTerm": "Bone Marrow Diseases"
          },
          {
            "ConditionAncestorId": "D000006402",
            "ConditionAncestorTerm": "Hematologic Diseases"
          },
          {
            "ConditionAncestorId": "D000011230",
            "ConditionAncestorTerm": "Precancerous Conditions"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M15507",
            "ConditionBrowseLeafName": "Syndrome",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10097",
            "ConditionBrowseLeafName": "Leukemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10107",
            "ConditionBrowseLeafName": "Leukemia, Myeloid",
            "ConditionBrowseLeafAsFound": "Myeloid Leukemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M17279",
            "ConditionBrowseLeafName": "Leukemia, Myeloid, Acute",
            "ConditionBrowseLeafAsFound": "Acute Myeloid Leukemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11297",
            "ConditionBrowseLeafName": "Myelodysplastic Syndromes",
            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M13316",
            "ConditionBrowseLeafName": "Preleukemia",
            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4286",
            "ConditionBrowseLeafName": "Bone Marrow Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8642",
            "ConditionBrowseLeafName": "Hematologic Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M13263",
            "ConditionBrowseLeafName": "Precancerous Conditions",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T3995",
            "ConditionBrowseLeafName": "Myeloid Leukemia",
            "ConditionBrowseLeafAsFound": "Myeloid Leukemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T182",
            "ConditionBrowseLeafName": "Acute Myeloid Leukemia",
            "ConditionBrowseLeafAsFound": "Acute Myeloid Leukemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T188",
            "ConditionBrowseLeafName": "Acute Non Lymphoblastic Leukemia",
            "ConditionBrowseLeafAsFound": "Acute Myeloid Leukemia",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T3993",
            "ConditionBrowseLeafName": "Myelodysplastic Syndromes",
            "ConditionBrowseLeafAsFound": "Myelodysplastic Syndrome",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC15",
            "ConditionBrowseBranchName": "Blood and Lymph Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}